Opportunities for the use of lentiviral vectors in human gene therapy

Curr Top Microbiol Immunol. 2002:261:245-54. doi: 10.1007/978-3-642-56114-6_13.

Authors

F Galimi¹, I M Verma

Affiliation

¹ Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.

PMID: 11892251
DOI: 10.1007/978-3-642-56114-6_13

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Animals
Central Nervous System Diseases / therapy
Genetic Therapy* / adverse effects
Genetic Vectors* / adverse effects
HIV Infections / therapy
Hematopoietic Stem Cells
Humans
Lentivirus / genetics*
Leukodystrophy, Metachromatic / therapy
Liver
Mucopolysaccharidosis VII / therapy
Muscle, Skeletal
Parkinson Disease / therapy
Retinal Degeneration / therapy
Safety